Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, in vitro and in vivo evaluation against MRSA and molecular docking studies of novel pleuromutilin derivatives bearing 1, 3, 4-oxadiazole linker
Jie Liu, Guang‐Yu Zhang, Zhe Zhang, et al.
Bioorganic Chemistry (2021) Vol. 112, pp. 104956-104956
Closed Access | Times Cited: 19

Showing 19 citing articles:

Synthesis and Biological Activities of Oxazolidinone Pleuromutilin Derivatives as a Potent Anti-MRSA Agent
Jing Xia, Yun Li, Cailu He, et al.
ACS Infectious Diseases (2023) Vol. 9, Iss. 9, pp. 1711-1729
Closed Access | Times Cited: 36
Design and Synthesis of Pleuromutilin Derivatives as Antibacterial Agents Using Quantitative Structure–Activity Relationship Model
Jiaming Zhang, Qinqin Liu, Haoxia Zhao, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2256-2256
Open Access | Times Cited: 2
Recent advances in developing modified C14 side chain pleuromutilins as novel antibacterial agents
Yue Liu, Qinjiang Zhou, Yiwen Huo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116313-116313
Closed Access | Times Cited: 2
Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing 4-aminothiophenol linker as promising antibacterial agents
Fei Chai, Jun Wang, Kexin Zhou, et al.
Bioorganic Chemistry (2022) Vol. 126, pp. 105859-105859
Closed Access | Times Cited: 9
Synthesis and evaluation of novel pleuromutilin derivatives targeting the 50S ribosomal subunit for antibacterial ability
Qinqin Liu, Hongjuan Zhang, Yunpeng Yi, et al.
European Journal of Medicinal Chemistry (2023) Vol. 262, pp. 115882-115882
Closed Access | Times Cited: 5
Antimicrobial activity, safety and pharmacokinetics evaluation of PMTM: A novel pleuromutilin candidate
Xingqian Zhou, Hongjuan Zhang, Yuhang Zhou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117378-117378
Open Access | Times Cited: 1
Anti-methicillin-resistant Staphylococcus aureus activity and safety evaluation of 14-O-[(5-ethoxycarbonyl-4,6-dimethylpyrimidine-2-yl) thioacetyl] mutilin (EDT)
Yuhang Zhou, Yunpeng Yi, Jing Yang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Design, synthesis and antibacterial evaluation of pleuromutilin derivatives
Guangxu Wu, Zihao Zhu, Jishun Li, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 59, pp. 116676-116676
Closed Access | Times Cited: 8
Design, Synthesis and Antibacterial Studies of 1,3,4‐Oxadiazole‐Fluoroquinolone Hybrids and Their Molecular Docking Studies
Ping Yang, Jiabao Luo, Lilei Zhang, et al.
ChemistrySelect (2021) Vol. 6, Iss. 46, pp. 13209-13214
Closed Access | Times Cited: 10
Design, synthesis, biological evaluation and molecular docking study of novel pleuromutilin derivatives containing substituted benzoxazole as antibacterial agents
Ren Jie, Qiwen Zhang, Xian‐Jin He, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 3
Discovery of Novel Pleuromutilin Derivatives as Potent Antibacterial Agents for the Treatment of MRSA Infection
Han-Qing Fang, Jie Zeng, Shou‐Kai Wang, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 931-931
Open Access | Times Cited: 6
Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Pleuromutilin Derivatives Containing Thiazole
Ke Li, Chao Lin, Yu-Han Hu, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 6, pp. 1980-1989
Closed Access
Design, synthesis, in vitro and in vivo evaluation and molecular docking study of novel pleuromutilin derivatives as antibacterial agents
Jie Liu, Jie Ren, Xiang-Yi Zuo, et al.
Fitoterapia (2024) Vol. 176, pp. 106046-106046
Closed Access
Synthesis and Design of New 1,3,4‐Oxadiazole Benzimidazole Hybrids as Potential Antibacterial Agents Against MRSA by Targeting FabI
Gowsia Akhter, Hinna Hamid, Bharti Dhawan, et al.
ChemistrySelect (2024) Vol. 9, Iss. 48
Closed Access
Design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups
Qi Wang, Jie Liu, Zi‐Dan Zhou, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2078-2091
Open Access | Times Cited: 3
Design, synthesis, antibacterial activity evaluation and molecular docking study of pleuromutilin derivatives bearing amide side chains
Zhuo‐Qi Zhang, Jie Liu, Guang‐Yu Zhang, et al.
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 4, pp. 564-579
Closed Access | Times Cited: 1
Design, synthesis, and biological evaluation of pleuromutilin derivatives containing 1,2,4‐triazole linker
Zi‐Dan Zhou, Yuhan Hu, Qi Wang, et al.
Drug Development Research (2023) Vol. 84, Iss. 4, pp. 703-717
Closed Access
Design, Synthesis and Biological Evaluation of Novel Pleuromutilin Derivatives Containing 6-Chloro-1-R-1H-pyrazolo[3,4-d]pyrimidine-4-amino Side Chain
Jun Wang, Yu-Han Hu, Kexin Zhou, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3975-3975
Open Access
Current Scenario of Pleuromutilin Derivatives with Antibacterial Potential (A Review)
Le Wang, Yong‐Qiang Tu, Weidong Tian
Russian Journal of General Chemistry (2023) Vol. 93, Iss. S4, pp. S908-S927
Closed Access
Page 1

Scroll to top